跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拜瑞妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rivaroxaban Tablets
Approved
化学药品
Rivaroxaban Tablets
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
Apr 27, 2022
Approval ID
b80bc44f65164d0b
Company
BAYER AG
Type
化学药品
Approval Details
Approval Id
b80bc44f65164d0b
Approval Number
国药准字HJ20181081
Generic Name
利伐沙班片
Generic Name En
Rivaroxaban Tablets
Trade Name
拜瑞妥
Brand Name
拜瑞妥
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg
Reg Date
2022-04-27
Expired Date
2027-04-26
Company Name
BAYER AG
Production Company Name
BAYER AG
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/bayer-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 27, 2022
Approval ID
b80bc44f65164d0b
Type
化学药品
Back to NMPA Approvals